Diabetes : perspectives in drug therapy /
| Other Authors: | |
|---|---|
| Format: | eBook |
| Language: | English |
| Published: |
Heidelberg [Germany] ; New York [N.Y.] :
Springer-Verlag,
[2011]
|
| Series: | Handbook of experimental pharmacology ;
v. 203. |
| Subjects: | |
| Online Access: | Connect to the full text of this electronic book |
Table of Contents:
- Targeting type 2 diabetes
- Dual acting and pan-PPAR activators as potential anti-diabetic therapies
- GLP-1 agonists and dipeptidyl-peptidase IV inhibitors
- Cannabinoids and endocannabinoids in metabolic disorders with focus on diabetes
- SGLT inhibitors as new therapeutic tools in the treatment of diabetes
- Inhibitors of 11[beta]-hydroxysteroid dehydrogenase type 1 in antidiabetic therapy
- Nampt and its potential role in inflammation and type 2 diabetes
- Inhibition of ganglioside biosynthesis as a novel therapeutic approach in insulin resistance
- Overcoming insulin resistance with ciliary neurotrophic factor
- Thermogenesis and related metabolic targets in anti-diabetic therapy
- Interleukin-targeted therapy for metabolic syndrome and type 2 diabetes
- Fructose-1, 6-bisphosphatase inhibitors for reducing excessive endogenous glucose production in type 2 diabetes
- AMP-activated protein kinase and metabolic control
- Mitochondria as potential targets in antidiabetic therapy
- Research and development of glucokinase activators for diabetes therapy : theoretical and practical aspects.